[The use of phosphate of betamethasone for the control of secondary reactions caused by Hetrazan in patients with onchocerciasis].
D000293:Adolescent; D000328:Adult; D001623:Betamethasone / Q000627:therapeutic use*; D002648:Child; D004049:Diethylcarbamazine / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000517:prevention & control*; D005132:Eye Manifestations; D005260:Female; D006166:Guatemala; D006801:Humans; D008297:Male; D008875:Middle Aged; D009855:Onchocerciasis / Q000188:drug therapy*; D012877:Skin Manifestations
D001623:Betamethasone; D004049:Diethylcarbamazine
El uso del fosfato de betametasona para controlar las reacciones secundarias producidas por Hetrazán en pacientes oncocercosos.